Mechanism of the radiosensitization induced by vinorelbine in human non-small cell lung cancer cells-Reference-Cited by-同舟云学术

Mechanism of the radiosensitization induced by vinorelbine in human non-small cell lung cancer cells

Published:2001-12 Issue:3 Volume:34 Page:451-460
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Fukuoka Kazuya,Arioka Hitoshi,Iwamoto Yasuo,Fukumoto Hisao,Kurokawa Hirokazu,Ishida Tomoyuki,Tomonari Akira,Suzuki Toshihiro,Usuda Jitsuo,Kanzawa Fumihiko,Saijo Nagahiro,Nishio Kazuto

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Non-small cell lung cancer. I. Biology, diagnosis,and staging;Ihde;Curr. Probl. Cancer,1991

2. Chemoradiation for locally advanced, unresectable NSCLC. New standard of care, emerging strategies;Gordon;Oncology (Huntington),1999

3. Gandara DR, Edelman MJ, Lara P, et al. Current status and novel therapeutic approaches in advanced non-small cell lung cancer. ASCO Educational Book 1999;362–369.

4. Curran, Jr WJ. Issues in the nonoperative management of patients with locally advanced non-small-cell lung cancer. ASCO Educational Book 1999;370–373.

5. Vinorelbine—a review of its pharmacological properties and clinical use in cancer chemotherapy;Goa;Drugs Aging Adis Int.,1994

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates;Critical Reviews in Oncology/Hematology;2024-03

2. Vinorelbine Improves the Efficacy of Sorafenib against Hepatocellular Carcinoma: A Promising Therapeutic Approach;International Journal of Molecular Sciences;2024-01-26

3. Everolimus Acts in Synergy with Vinorelbine to Suppress the Growth of Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-12-19

4. Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges;Genes;2023-10-04

5. Clinical outcomes of curative-intent multimodal management of chemorefractory nonmetastatic inflammatory breast cancer;Strahlentherapie und Onkologie;2022-06-01